ViiV HEALTHCARE ULC, ET AL. v. TEVA CANADA LIMITED, ET AL.
Summary of A-452-14
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Interloc.) - Patent Act
Detected Type: Appeal (S.27 - Final) - Others [from T-1517-13 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| GLAXO GROUP LTD | ||
| MINISTER OF HEALTH (THE) | ||
| TEVA CANADA LTD | ||
| VIIV HEALTHCARE UK LTD | ||
| VIIV HEALTHCARE ULC | Norton Rose FULBRIGHT CA LLP | KIERANS, PATRICK E |
| Name | Number |
|---|---|
| 2289753 |
Patented Medicine: Abacavir (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Viiv Healthcare ULC et al. v. Teva Canada Limited et al. 2015 FCA 93 | Apr 15, 2015 | These appeals concern the eligibility for listing of Canadian Patent No. 2,289,753 (the '753 Patent) against KIVEXA, a drug marketed by ViiV Healthcare ULC, ViiV Healthcare UK Ltd., and Glaxo Group Limited (collectively, the appellants) under paragraph 4(2)(a) of the PM(NOC) Regulations. For Reasons cited at 2014 PC 328, the Prothonotary found that the '753 Patent was not eligible for listing against KIVEXA. In a decision made in respect of both Teva and Apotex, Justice Hughes upheld the decisions of the Prothonotary (2014 FC 893). In our view, both the Prothonotary and the Federal Court judge correctly concluded that Gilead (2012 FCA 254) applies to the facts of this case. In Gilead, this Court found that paragraph 4(2)(a) of the Regulations sets an exacting threshold of specificity between what is claimed in the patent and what has been approved in the NOC - a patent that does not explicitly claim all of the medicinal ingredients contained in the drug for which the NOC was issued cannot be listed against that drug. |
| ViiV Healthcare ULC v. Teva Canada Limited 2015 FCA 33 | Feb 2, 2015 | Canada’s Research-Based Pharmaceutical Companies (the “Association”) moves for leave to intervene in this appeal. The appeal is from the judgment of the Federal Court (per Justice Hughes): 2014 FC 328. The Federal Court found that the appellants’ patent was not eligible for inclusion in the Patent Register under the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133. |
This is an appeal from a decision dated 2014-09-18 in T-1517-13. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(56) 2016-05-20 - OttawaCertified French translation of the reasons for judgment delivered 15-APR-2015 filed on 20-MAY-2016
Certified French translation of the order / doc. # 44 delivered 02-FEB-2015 filed on 25-FEB-2016 entered in J. & O. Book, volume 293 page(s) 452 - 454
APPELLANTS' PRESENTATION received at hearing on 13-APR-2015
APPELLANTS' COMPENDIUM received at hearing on 13-APR-2015
Certified French translation of the reasons for order / doc. # 45 delivered 02-FEB-2015 filed on 05-JUN-2015
Memorandum to file from the Registry of the FCA dated 23-APR-2015 transmitting a copy of the Judgment and Reasons for Judgment to Justice Hughes, Prothonotary Milczynski and the Applications section of the FC. placed on file.
Acknowledgment of Service received from ALL PARTIES with respect to THE JUDGMENT (DOC. 52) AND REASONS FOR JUDGMENT (DOC. 53) placed on file on 15-APR-2015
Reasons for Judgment of the Court/ The Honourable Mr. Justice Near The Honourable Mr. Justice Ryer The Honourable Mr. Justice Rennie Reasons delivered from the Bench by The Honourable Mr. Justice Near at Toronto on 15-APR-2015 The Court's decision is with regard to Appeal Filed on 15-APR-2015 Same reasons also filed in A-453-14 Copies sent to parties
Judgment dated 15-APR-2015 rendered by The Honourable Mr. Justice Ryer The Honourable Mr. Justice Near The Honourable Mr. Justice Rennie Matter considered with personal appearance The Court's decision is with regard to Appeal Result: THE APPEALS ARE DISMISSED WITH COSTS FIXED IN THE AMOUNT OF $5,000 IN EACH APPEAL AWARDED TO THE RESPONDENT TEVA CANADA LIMITED AND $2,500 IN EACH APPEAL AWARDED TO THE RESPONDENT APOTEX INC. Filed on 15-APR-2015 certified copies sent to parties entered in J. & O. Book, volume 289 page(s) 176 - 177 (Final decision)
This matter comes on for hearing on 13-APR-2015 at Toronto before The Honourable Mr. Justice Ryer The Honourable Mr. Justice Near The Honourable Mr. Justice Rennie Appearances: MR. PATRICK KIERANS / MS. LOUISA PONTRELLI / MR. CHRISTOPHER A. GUERREIRO / MR. DANIEL DANIELE 416.216.4000 for APPELLANTS MR. DAVID W. AITKEN / MR. SCOTT A. BEESER 613.695.5858 for TEVA CANADA LIMITED (RESPONDENT IN A-452-14) MR. BEN HACKETT / MR. JARO MAZZOLA 416.979.2211 for APOTEX INC. (RESPONDENT IN A-453-14) MR. ERIC PETERSON 416.952.6334 for RESPONDENT - THE MINISTER OF HEALTH Language of Hearing: E Court Usher: ANNE STREET Duration: on 13-APR-2015 from 09:30 to 03:35 Courtroom : Courtroom No. 7-C - Toronto Court Registrar Maggie Lau on 15-APR-2015 from 11:58 to 12:07 Courtroom : Courtroom No. 7-C - Toronto Court Registrar Maggie Lau Total duration: 1D9MINS Before the Court: appeal Result: dismissed Reasons delivered from the Bench Comments: HEARD TOGETHER WITH CONSOLIDATED FILE A-453-14. APPELLANTS PROVIDED TO THE COURT THE APPELLANTS' COMPENDIUM AND APPELLANTS' PRESENTATION. COURT DELIVERED REASONS FROM THE BENCH ON 15-APR-2015. Minutes of Hearing entered in Vol. 215 page(s) 1 - 7 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of LOUISA PONTRELLI confirming service of DOC 50 upon Respondent by personal service on 13-MAR-2015 filed on 13-MAR-2015
Joint Book of Authorities consisting of 2 volume(s) on behalf of Appellant Filed on 13-MAR-2015 3 copy(ies) for the Court stored in Ottawa
Transmission of the hearing date order: to Mr. Kierans's office (by e-mail, receipt acknowledged), to Mr. Peterson (by e-mail, receipt acknowledged), to Mr. Aitken (by fax, successful transmission) and to Mr. Brodkin (by fax, successful transmission) placed on file on 20-FEB-2015
Order (time and place) dated 10-FEB-2015 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator fixing the Appeals (A-452-14 and A-453-14) to be heard at Special Sitting in Toronto on 13-APR-2015 to begin at 09:30 Filed on 10-FEB-2015 cc's sent to parties and to the Toronto local office entered in J. & O. Book, volume 288 page(s) 160 - 161 Transmittal letters placed on file
Communication from Registry to Judicial Administrator dated 06-FEB-2015 re: fixing the date for the Hearing. (Tor)
Acknowledgment of Receipt received from Ms. Pontrelli (email), Mr. Peterson (email), Mr. Mazzola (email) and Mr. Beeser (email) with respect to the Direction of the Court dated February 5, 2015, placed on file on 06-FEB-2015
Affidavit of Daniel Costa on behalf of the Respondent (Apotex) sworn on 02-FEB-2015 confirming service of the Respondent's Memorandum of Fact and Law on the respondent by personal service on 02-FEB-2015 filed on 03-FEB-2015
Affidavit of Daniel Costa on behalf of the Respondent (Apotex) sworn on 02-FEB-2015 confirming service of the Respondent's Memorandum of Fact and Law on the appellant by personal service on 02-FEB-2015 filed on 03-FEB-2015
Memorandum of fact and law on behalf of the Respondent (Apotex) filed on 03-FEB-2015 3 judges' copies stored in Ottawa
Written directions of the Court: The Honourable Mr. Justice Stratas dated 05-FEB-2015 directing "The respondents' memoranda may be accepted for filing." received on 06-FEB-2015 Confirmed in writing to the party(ies)
Communication from Registry to Judicial Administrator dated 05-FEB-2015 re: seeking the Court's direction as to whether the Apotex & Teva's Memoranda should be accepted for filing.
Memorandum to file from Toronto dated 03-FEB-2015 Request for Court Direction sent to OTT - Re:letters from Respondent(Teva); Respondent (Apotex) - filing of Memorandums of Fact and Law. 5 copies of Memorandum and Service (2 Affidavits of Service) - Apotex 5 copies of Memorandum and Service (Solicitor's Certificate of Service)- Teva placed on file.
Letter from Respondent - Teva dated 03-FEB-2015 request for Court Direction to file their Memorandum of Fact and law submitted for filing on 2-FEB-2015. received on 03-FEB-2015
Letter from Respondent, Apotex Inc. dated 03-FEB-2015 requesting that their memorandum of fact and law be accepted for filing. received on 03-FEB-2015
Communication from Registry to Judicial Administrator dated 03-FEB-2015 re: fixing date and place for hearing
Acknowledgment of Receipt received from all parties (by fax) with respect to the Order and Reasons for Order dated February 2, 2015 placed on file on 02-FEB-2015
Reasons for Order rendered by The Honourable Mr. Justice Stratas dated 02-FEB-2015 The Court's decision is with regard to the motion / document number 24 Filed on 02-FEB-2015
Order dated 02-FEB-2015 rendered by The Honourable Mr. Justice Stratas Matter considered without personal appearance The Court's decision is with regard to the motion / document number 24 Result: dismissed Filed on 02-FEB-2015 entered in J. & O. Book, volume 288 page(s) 96 - 97
Solicitor's certificate of service on behalf of Scott a. Beeser confirming service of Doc.42 upon Appellant by personal service on 02-FEB-2015 confirming service Doc.42 upon Respondent by personal service on 02-FEB-2015 filed on 02-FEB-2015
Memorandum of fact and law on behalf of the respondent filed on 02-FEB-2015 3 judges' copies stored in Ottawa
Communication from Registry to Judicial Administrator dated 29-JAN-2015 re: Motion Doc. 24 (pd: Jan 27, 2015)
Affidavit of Susan Burkhardt on behalf of the appellant sworn on 27-JAN-2015 confirming service of Written Representations in Reply on Canada's Research-Based Pharmaceutical Companies by personal service on 27-JAN-2015 filed on 27-JAN-2015
Affidavit of Mark Da Silva on behalf of the appellant sworn on 27-JAN-2015 confirming service of the written represenations in reply on the Appellants, ViiV Healthcare ULC, ViiV Healthcare UK Limited and Glaxo Group Limited by courier and fax on 27-JAN-2015 confirming service written representations in reply on The Respondent/The Minister of Health by telecopier on 27-JAN-2015 confirming service the written representations in reply on the Respondent Apotex Inc by telecopier on 27-JAN-2015 filed on 27-JAN-2015
Written representations on behalf of Proposed Intervener Re: Motion to Intervene filed on 27-JAN-2015
Covering letter from Proposed Intervener dated 27-JAN-2015 concerning Written Representations in Reply regarding clients motion to interevene in the above noted proceedings placed on file on 27-JAN-2015
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of doc. 37 and Authorities upon all parties by personal service on 23-JAN-2015 filed on 23-JAN-2015
Book of Authorities consisting of 1 volume(s) on behalf of Respondent(TEVA) received on 23-JAN-2015 1 copy(ies) for the Court stored in Ottawa
Motion Record in response to Motion Doc. No. 24 containing the following original document(s): 35 36 Number of copies received: 3 on behalf of Respondent(TEVA) filed on 23-JAN-2015
Written representations contained within a Motion Record on behalf of Respondent(TEVA) in opposition to doc. 24 filed on 23-JAN-2015
Affidavit of Anna Hucman contained within a Motion Record on behalf of Respondent(TEVA) sworn on 23-JAN-2015 in opposition to 24 with attached exhibit(s) a-c filed on 23-JAN-2015
Letter from the appellant dated 23-JAN-2015 further to their letter of January 22, 2015, advising the Court that counsel for Rx&D as inadvertently excluded from the original list of recipients copied and have provided counsel with a copy of its letter of January 22, 2015, received on 23-JAN-2015
Affidavit of Johanna Palacios on behalf of the respondent sworn on 23-JAN-2015 confirming service of doc 33, Book of Authorities on all parties by courier on 23-JAN-2015 filed on 23-JAN-2015
Book of Authorities consisting of 1 volume(s) on behalf of Respondent Apotex Inc. received on 23-JAN-2015
Motion Record in response to Motion Doc. No. 24 containing the following original document(s): 31 32 Number of copies received: 3 on behalf of Respondent filed on 23-JAN-2015
Written representations contained within a Motion Record on behalf of the respondent in opposition to MOTION DOC 24 filed on 23-JAN-2015
Affidavit of Lisa Ebdon contained within a Motion Record on behalf of the respondent sworn on 23-JAN-2015 in opposition to motion doc 24 with attached exhibit(s) A-K filed on 23-JAN-2015
Letter from the appellant dated 22-JAN-2015 advising that they do not object to the motion by Rx&D, provided the proposed intervention does not delay the hearing of the appeals, received on 23-JAN-2015
Affidavit of William Platt on behalf of DOJ-Minister of Health sworn on 14-JAN-2015 confirming service of doc. 29 on all parties by electronic mail on 13-JAN-2015 with attached exhibit(s) a-c filed on 14-JAN-2015
Memorandum of fact and law on behalf of the Minister of Health filed on 14-JAN-2015 3 judges' copies stored in Ottawa
Solicitor's certificate of service on behalf of Will Boyer confirming service of doc. #27 upon Appellants by personal service on 13-JAN-2015 confirming service doc. #27 upon Respondent - Teva Canada Ltd. by personal service on 13-JAN-2015 confirming service doc. #27 upon Respondent - Apotex Inc. by personal service on 13-JAN-2015 confirming service doc. #27 upon Respondent - The Minister of Health by personal service on 13-JAN-2015 filed on 13-JAN-2015
Motion Record containing the following original document(s): 24 25 26 Number of copies received: 3 on behalf of Proposed Intervener - Research-Based Pharmaceutical Companies filed on 13-JAN-2015
Written representations contained within a Motion Record on behalf of Proposed Intervener - Rx&D in support of doC. #24 filed on 13-JAN-2015
Affidavit of Declan B. Hamill contained within a Motion Record on behalf of Proposed Intervener - Rx&D sworn on 12-JAN-2015 in support of doc. #24 with attached exhibit(s) "A" & "B" filed on 13-JAN-2015
Notice of motion contained within a Motion Record on behalf of Proposed Intervener - Research-Based Pharmaceutical Companies for an Order pursuan to Rule 109 of the Federal Court Rules for: (a) granting Rx&D leave to intervene in this appeal; (b) adding Rx&D as an intervener in the style of cause; (c) permitting Rx&D to file a Memorandum of Fact and Law not exceeding twenty (20) pages in length within 15 days from the date of the Order granting Rx&D intervention status; (d) permitting Rx&D to make not more than one (1) hour of oral submissions at the hearing of the appeal; (e) granted Rx&D a right to seek leave to appeal to the Supreme Court of Canada in the event that the present appeal is dismissed; and (f) such further and othe relief as this Court deems appropriate. in writing filed on 13-JAN-2015
Covering letter from Appellant dated 09-JAN-2015 concerning CD containing appellant's documents placed on file on 12-JAN-2015
Communication from Registry to Judicial Administrator dated 19-DEC-2014 re: fixing the date for the hearing (TOR)
Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc 22 upon all respondents by telecopier on 16-DEC-2014 filed on 16-DEC-2014
Requisition for hearing - Appeal from Appellant filed on 16-DEC-2014
Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc 20 upon all respondents by email on consent on 16-DEC-2014 filed on 16-DEC-2014
Memorandum of fact and law on behalf of the appellant, Viiv Healthcare filed on 16-DEC-2014
Solicitor's certificate of service on behalf of LOUISA PONTRELLI confirming service of DOC 18 upon all parties by electronic secure file transfer on consent on 01-DEC-2014 filed on 01-DEC-2014
Appeal Book consisting of 13 volume(s) prepared by the appellant filed on 01-DEC-2014 3 judges' copies stored in Ottawa
Acknowledgment of Receipt received from all parties by way of fax confirmation with respect to Order of the Court (Boivin J.A.) dated 21-NOV-2014 doc. no. 17 placed on file on 24-NOV-2014
Order dated 21-NOV-2014 rendered by The Honourable Mr. Justice Boivin Matter considered without personal appearance The Court's decision is with regard to the motion / document number 8 Result: granted Files A-452-14 (Lead) consolidated with A-453-14 Filed on 21-NOV-2014 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 287 page(s) 107 - 110
Communication from Registry to Judicial Administrator dated 06-NOV-2014 re: Appellants's Motion Doc. 8 (perfected dated November 5, 2014
Letter from the appellant dated 05-NOV-2014 in reply to its motion filed October 23, 2014 received on 05-NOV-2014
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of doc 15 upon all parties by email on consent on 03-NOV-2014 filed on 03-NOV-2014
Motion Record in response to Motion Doc. No. 8 containing the following original document(s): 13 14 Number of copies received: 3 on behalf of TEVA CANADA LIMITED filed on 03-NOV-2014
Written representations contained within a Motion Record on behalf of TEVA CANADA LIMITED in opposition to doc 8 filed on 03-NOV-2014
Affidavit of Anna Hucman contained within a Motion Record on behalf of TEVA Canada Limited sworn on 03-NOV-2014 in opposition to Doc 8 filed on 03-NOV-2014
Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc. 11 & Authorities upon Respondent by personal service on 23-OCT-2014 filed on 23-OCT-2014
Book of Authorities consisting of 1 volume(s) on behalf of Appellant received on 23-OCT-2014 1 copy(ies) for the Court stored in Ottawa
Motion Record containing the following original document(s): 8 9 10 Number of copies received: 3 on behalf of Appellant filed on 23-OCT-2014
Written representations contained within a Motion Record on behalf of the appellant in support of doc 8 filed on 23-OCT-2014
Affidavit of Christian Landeta contained within a Motion Record on behalf of the appellant sworn on 23-OCT-2014 in support of doc. 8 with attached exhibit(s) A-s filed on 23-OCT-2014
Notice of motion contained within a Motion Record on behalf of the appellant an Order to consolidate the appeals in Court Files: A-452-14 and A-453-14 and an Order granting an expedited hearing. in writing filed on 23-OCT-2014
Memorandum to file from FCA Registry dated 16-OCT-2014 forwarding a copy of the Notice of Appeal to the Honourable Justice Hughes, the FC Applications Section and Prothonotary Milczynski placed on file.
Affidavit of James Adeney on behalf of the respondent, the Minister of Health sworn on 09-OCT-2014 confirming service of doc 6 on the applicants and the respondent, TEVA Canada by telecopier on 09-OCT-2014 with attached exhibit(s) A filed on 09-OCT-2014
Notice of appearance on behalf of the respondent, the Minister of Health filed on 09-OCT-2014
Solicitor's certificate of service on behalf of Louisa Pontrelli confirming service of doc 1 upon respondent, Teva Canada Limited by personal service on 07-OCT-2014 filed on 08-OCT-2014
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of Teva's (R.) Notice of Appearance doc. no. 3 upon all parties by telecopier on 08-OCT-2014 filed on 08-OCT-2014
Notice of appearance on behalf of Respondent Teva filed on 08-OCT-2014
Copy of doc 1 with proof of service on The Minister of Health on 07-OCT-2014 filed on 07-OCT-2014
Notice of Appeal filed on 07-OCT-2014 against a decision 18-SEP-2014, T-1517-13, Hughes, J. Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: